Project
Illumina Body Map 2
Navigation
Downloads
Results for ZEB1
Z-value: 4.11
Motif logo
Transcription factors associated with ZEB1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
ZEB1
|
ENSG00000148516.17 | zinc finger E-box binding homeobox 1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| ZEB1 | hg19_v2_chr10_+_31608054_31608156 | -0.05 | 7.7e-01 | Click! |
Activity profile of ZEB1 motif
Sorted Z-values of ZEB1 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr17_-_7165662 | 22.16 |
ENST00000571881.2
ENST00000360325.7 |
CLDN7
|
claudin 7 |
| chr19_+_6464243 | 19.65 |
ENST00000600229.1
ENST00000356762.3 |
CRB3
|
crumbs homolog 3 (Drosophila) |
| chr19_-_10697895 | 17.03 |
ENST00000591240.1
ENST00000589684.1 ENST00000591676.1 ENST00000250244.6 ENST00000590923.1 |
AP1M2
|
adaptor-related protein complex 1, mu 2 subunit |
| chr1_-_27286897 | 14.53 |
ENST00000320567.5
|
C1orf172
|
chromosome 1 open reading frame 172 |
| chr19_+_6464502 | 13.48 |
ENST00000308243.7
|
CRB3
|
crumbs homolog 3 (Drosophila) |
| chr8_+_95653302 | 12.90 |
ENST00000423620.2
ENST00000433389.2 |
ESRP1
|
epithelial splicing regulatory protein 1 |
| chr8_+_120220561 | 12.52 |
ENST00000276681.6
|
MAL2
|
mal, T-cell differentiation protein 2 (gene/pseudogene) |
| chr7_-_16921601 | 12.32 |
ENST00000402239.3
ENST00000310398.2 ENST00000414935.1 |
AGR3
|
anterior gradient 3 |
| chr8_+_95653427 | 12.11 |
ENST00000454170.2
|
ESRP1
|
epithelial splicing regulatory protein 1 |
| chr14_-_65409502 | 11.67 |
ENST00000389614.5
|
GPX2
|
glutathione peroxidase 2 (gastrointestinal) |
| chr8_+_95653373 | 11.45 |
ENST00000358397.5
|
ESRP1
|
epithelial splicing regulatory protein 1 |
| chr16_+_68771128 | 11.34 |
ENST00000261769.5
ENST00000422392.2 |
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial) |
| chr14_-_65409438 | 11.15 |
ENST00000557049.1
|
GPX2
|
glutathione peroxidase 2 (gastrointestinal) |
| chr5_+_68788594 | 10.92 |
ENST00000396442.2
ENST00000380766.2 |
OCLN
|
occludin |
| chr8_+_102504651 | 10.74 |
ENST00000251808.3
ENST00000521085.1 |
GRHL2
|
grainyhead-like 2 (Drosophila) |
| chr20_+_44098385 | 10.44 |
ENST00000217425.5
ENST00000339946.3 |
WFDC2
|
WAP four-disulfide core domain 2 |
| chr20_+_44098346 | 10.14 |
ENST00000372676.3
|
WFDC2
|
WAP four-disulfide core domain 2 |
| chr17_-_39684550 | 10.03 |
ENST00000455635.1
ENST00000361566.3 |
KRT19
|
keratin 19 |
| chr12_+_7072354 | 9.94 |
ENST00000537269.1
|
U47924.27
|
U47924.27 |
| chr7_-_16844611 | 9.64 |
ENST00000401412.1
ENST00000419304.2 |
AGR2
|
anterior gradient 2 |
| chr19_+_38755042 | 9.35 |
ENST00000301244.7
|
SPINT2
|
serine peptidase inhibitor, Kunitz type, 2 |
| chr19_+_38755203 | 9.12 |
ENST00000587090.1
ENST00000454580.3 |
SPINT2
|
serine peptidase inhibitor, Kunitz type, 2 |
| chr21_-_42879909 | 9.10 |
ENST00000458356.1
ENST00000398585.3 ENST00000424093.1 |
TMPRSS2
|
transmembrane protease, serine 2 |
| chr19_+_38755237 | 8.58 |
ENST00000587516.1
|
SPINT2
|
serine peptidase inhibitor, Kunitz type, 2 |
| chr7_-_73184588 | 8.31 |
ENST00000395145.2
|
CLDN3
|
claudin 3 |
| chr12_-_53298841 | 8.20 |
ENST00000293308.6
|
KRT8
|
keratin 8 |
| chr8_+_102504979 | 8.12 |
ENST00000395927.1
|
GRHL2
|
grainyhead-like 2 (Drosophila) |
| chr17_-_36105009 | 8.04 |
ENST00000560016.1
ENST00000427275.2 ENST00000561193.1 |
HNF1B
|
HNF1 homeobox B |
| chr12_-_6484715 | 7.78 |
ENST00000228916.2
|
SCNN1A
|
sodium channel, non-voltage-gated 1 alpha subunit |
| chr4_-_77819002 | 7.65 |
ENST00000334306.2
|
SOWAHB
|
sosondowah ankyrin repeat domain family member B |
| chr15_+_41136586 | 7.64 |
ENST00000431806.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
| chr1_-_153588765 | 7.58 |
ENST00000368701.1
ENST00000344616.2 |
S100A14
|
S100 calcium binding protein A14 |
| chr21_-_42880075 | 7.56 |
ENST00000332149.5
|
TMPRSS2
|
transmembrane protease, serine 2 |
| chr19_+_55587266 | 7.53 |
ENST00000201647.6
ENST00000540810.1 |
EPS8L1
|
EPS8-like 1 |
| chr3_-_121740969 | 7.53 |
ENST00000393631.1
ENST00000273691.3 ENST00000344209.5 |
ILDR1
|
immunoglobulin-like domain containing receptor 1 |
| chr12_-_6484376 | 7.52 |
ENST00000360168.3
ENST00000358945.3 |
SCNN1A
|
sodium channel, non-voltage-gated 1 alpha subunit |
| chr1_-_21948906 | 7.42 |
ENST00000374761.2
ENST00000599760.1 |
RAP1GAP
|
RAP1 GTPase activating protein |
| chr14_-_61747949 | 7.38 |
ENST00000355702.2
|
TMEM30B
|
transmembrane protein 30B |
| chr12_+_52626898 | 7.27 |
ENST00000331817.5
|
KRT7
|
keratin 7 |
| chr7_+_140103842 | 7.22 |
ENST00000495590.1
ENST00000275874.5 ENST00000537763.1 |
RAB19
|
RAB19, member RAS oncogene family |
| chr1_-_153588334 | 7.21 |
ENST00000476873.1
|
S100A14
|
S100 calcium binding protein A14 |
| chr1_+_200863949 | 7.10 |
ENST00000413687.2
|
C1orf106
|
chromosome 1 open reading frame 106 |
| chr8_-_144815966 | 7.03 |
ENST00000388913.3
|
FAM83H
|
family with sequence similarity 83, member H |
| chr19_+_7660716 | 6.97 |
ENST00000160298.4
ENST00000446248.2 |
CAMSAP3
|
calmodulin regulated spectrin-associated protein family, member 3 |
| chr17_+_37894179 | 6.95 |
ENST00000577695.1
ENST00000309156.4 ENST00000309185.3 |
GRB7
|
growth factor receptor-bound protein 7 |
| chr11_-_14993819 | 6.68 |
ENST00000396372.2
ENST00000361010.3 ENST00000359642.3 ENST00000331587.4 |
CALCA
|
calcitonin-related polypeptide alpha |
| chr11_+_34642656 | 6.58 |
ENST00000257831.3
ENST00000450654.2 |
EHF
|
ets homologous factor |
| chr2_-_219925189 | 6.50 |
ENST00000295731.6
|
IHH
|
indian hedgehog |
| chr5_-_147211226 | 6.36 |
ENST00000296695.5
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1 |
| chr21_-_31588365 | 6.34 |
ENST00000399899.1
|
CLDN8
|
claudin 8 |
| chr1_+_95285896 | 6.32 |
ENST00000446120.2
ENST00000271227.6 ENST00000527077.1 ENST00000529450.1 |
SLC44A3
|
solute carrier family 44, member 3 |
| chr11_+_394196 | 6.28 |
ENST00000331563.2
ENST00000531857.1 |
PKP3
|
plakophilin 3 |
| chr11_+_27062502 | 6.28 |
ENST00000263182.3
|
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
| chr17_-_46035187 | 6.26 |
ENST00000300557.2
|
PRR15L
|
proline rich 15-like |
| chr11_+_27062272 | 6.25 |
ENST00000529202.1
ENST00000533566.1 |
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
| chr2_-_166651191 | 6.12 |
ENST00000392701.3
|
GALNT3
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3 (GalNAc-T3) |
| chr11_-_64612041 | 6.07 |
ENST00000342711.5
|
CDC42BPG
|
CDC42 binding protein kinase gamma (DMPK-like) |
| chr19_+_35607166 | 6.06 |
ENST00000604255.1
ENST00000346446.5 ENST00000344013.6 ENST00000603449.1 ENST00000406988.1 ENST00000605550.1 ENST00000604804.1 ENST00000605552.1 |
FXYD3
|
FXYD domain containing ion transport regulator 3 |
| chr16_+_23194033 | 5.97 |
ENST00000300061.2
|
SCNN1G
|
sodium channel, non-voltage-gated 1, gamma subunit |
| chr1_-_207119738 | 5.93 |
ENST00000356495.4
|
PIGR
|
polymeric immunoglobulin receptor |
| chr14_-_67859422 | 5.92 |
ENST00000556532.1
|
PLEK2
|
pleckstrin 2 |
| chr21_-_31588338 | 5.83 |
ENST00000286809.1
|
CLDN8
|
claudin 8 |
| chr1_-_209979375 | 5.81 |
ENST00000367021.3
|
IRF6
|
interferon regulatory factor 6 |
| chr4_+_25657444 | 5.80 |
ENST00000504570.1
ENST00000382051.3 |
SLC34A2
|
solute carrier family 34 (type II sodium/phosphate contransporter), member 2 |
| chr1_-_43751276 | 5.79 |
ENST00000423420.1
|
C1orf210
|
chromosome 1 open reading frame 210 |
| chr2_-_20424844 | 5.79 |
ENST00000403076.1
ENST00000254351.4 |
SDC1
|
syndecan 1 |
| chr1_-_201368653 | 5.78 |
ENST00000367313.3
|
LAD1
|
ladinin 1 |
| chr17_+_37894570 | 5.76 |
ENST00000394211.3
|
GRB7
|
growth factor receptor-bound protein 7 |
| chr15_+_41136734 | 5.75 |
ENST00000568580.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
| chr2_-_166651152 | 5.70 |
ENST00000431484.1
ENST00000412248.1 |
GALNT3
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3 (GalNAc-T3) |
| chr19_+_35532612 | 5.61 |
ENST00000600390.1
ENST00000597419.1 |
HPN
|
hepsin |
| chr1_+_3370990 | 5.57 |
ENST00000378378.4
|
ARHGEF16
|
Rho guanine nucleotide exchange factor (GEF) 16 |
| chr1_-_155162658 | 5.57 |
ENST00000368389.2
ENST00000368396.4 ENST00000343256.5 ENST00000342482.4 ENST00000368398.3 ENST00000368390.3 ENST00000337604.5 ENST00000368392.3 ENST00000438413.1 ENST00000368393.3 ENST00000457295.2 ENST00000338684.5 ENST00000368395.1 |
MUC1
|
mucin 1, cell surface associated |
| chr15_+_41136216 | 5.56 |
ENST00000562057.1
ENST00000344051.4 |
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
| chr1_+_60280458 | 5.56 |
ENST00000455990.1
ENST00000371208.3 |
HOOK1
|
hook microtubule-tethering protein 1 |
| chr19_-_54676884 | 5.52 |
ENST00000376591.4
|
TMC4
|
transmembrane channel-like 4 |
| chr19_+_35606777 | 5.51 |
ENST00000604404.1
ENST00000435734.2 ENST00000603181.1 |
FXYD3
|
FXYD domain containing ion transport regulator 3 |
| chr1_-_161059380 | 5.47 |
ENST00000368012.3
|
PVRL4
|
poliovirus receptor-related 4 |
| chr19_-_54676846 | 5.47 |
ENST00000301187.4
|
TMC4
|
transmembrane channel-like 4 |
| chr2_-_31030277 | 5.46 |
ENST00000534090.2
ENST00000295055.8 |
CAPN13
|
calpain 13 |
| chr6_-_136871957 | 5.43 |
ENST00000354570.3
|
MAP7
|
microtubule-associated protein 7 |
| chr19_-_36001286 | 5.43 |
ENST00000602679.1
ENST00000492341.2 ENST00000472252.2 ENST00000602781.1 ENST00000402589.2 ENST00000458071.1 ENST00000436012.1 ENST00000443640.1 ENST00000450261.1 ENST00000467637.1 ENST00000480502.1 ENST00000474928.1 ENST00000414866.2 ENST00000392206.2 ENST00000488892.1 |
DMKN
|
dermokine |
| chr1_+_16348366 | 5.42 |
ENST00000375692.1
ENST00000420078.1 |
CLCNKA
|
chloride channel, voltage-sensitive Ka |
| chr1_-_201368707 | 5.40 |
ENST00000391967.2
|
LAD1
|
ladinin 1 |
| chr11_+_27062860 | 5.37 |
ENST00000528583.1
|
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
| chr14_-_61748550 | 5.34 |
ENST00000555868.1
|
TMEM30B
|
transmembrane protein 30B |
| chr17_-_74023474 | 5.31 |
ENST00000301607.3
|
EVPL
|
envoplakin |
| chr1_-_59043166 | 5.27 |
ENST00000371225.2
|
TACSTD2
|
tumor-associated calcium signal transducer 2 |
| chr19_+_35739597 | 5.26 |
ENST00000361790.3
|
LSR
|
lipolysis stimulated lipoprotein receptor |
| chr19_+_35739782 | 5.22 |
ENST00000347609.4
|
LSR
|
lipolysis stimulated lipoprotein receptor |
| chr19_+_35739631 | 5.22 |
ENST00000602003.1
ENST00000360798.3 ENST00000354900.3 |
LSR
|
lipolysis stimulated lipoprotein receptor |
| chr15_+_45722727 | 5.19 |
ENST00000396650.2
ENST00000558435.1 ENST00000344300.3 |
C15orf48
|
chromosome 15 open reading frame 48 |
| chr2_+_47596287 | 5.18 |
ENST00000263735.4
|
EPCAM
|
epithelial cell adhesion molecule |
| chr1_-_209979465 | 5.15 |
ENST00000542854.1
|
IRF6
|
interferon regulatory factor 6 |
| chr11_+_706113 | 5.10 |
ENST00000318562.8
ENST00000533256.1 ENST00000534755.1 |
EPS8L2
|
EPS8-like 2 |
| chr8_-_6735451 | 5.09 |
ENST00000297439.3
|
DEFB1
|
defensin, beta 1 |
| chr19_-_11529225 | 5.06 |
ENST00000567431.1
|
RGL3
|
ral guanine nucleotide dissociation stimulator-like 3 |
| chr1_+_156030937 | 5.01 |
ENST00000361084.5
|
RAB25
|
RAB25, member RAS oncogene family |
| chr12_+_56473628 | 4.99 |
ENST00000549282.1
ENST00000549061.1 ENST00000267101.3 |
ERBB3
|
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3 |
| chr16_-_68269971 | 4.96 |
ENST00000565858.1
|
ESRP2
|
epithelial splicing regulatory protein 2 |
| chr4_-_40632605 | 4.95 |
ENST00000514014.1
|
RBM47
|
RNA binding motif protein 47 |
| chr17_-_74023291 | 4.88 |
ENST00000586740.1
|
EVPL
|
envoplakin |
| chr6_+_27215471 | 4.86 |
ENST00000421826.2
|
PRSS16
|
protease, serine, 16 (thymus) |
| chr1_+_16348497 | 4.81 |
ENST00000439316.2
|
CLCNKA
|
chloride channel, voltage-sensitive Ka |
| chr21_-_43187231 | 4.79 |
ENST00000332512.3
ENST00000352483.2 |
RIPK4
|
receptor-interacting serine-threonine kinase 4 |
| chr19_+_45281118 | 4.78 |
ENST00000270279.3
ENST00000341505.4 |
CBLC
|
Cbl proto-oncogene C, E3 ubiquitin protein ligase |
| chr20_-_18038521 | 4.77 |
ENST00000278780.6
|
OVOL2
|
ovo-like zinc finger 2 |
| chr1_+_16348525 | 4.75 |
ENST00000331433.4
|
CLCNKA
|
chloride channel, voltage-sensitive Ka |
| chr14_-_106330458 | 4.75 |
ENST00000461719.1
|
IGHJ4
|
immunoglobulin heavy joining 4 |
| chr4_-_74486217 | 4.72 |
ENST00000335049.5
ENST00000307439.5 |
RASSF6
|
Ras association (RalGDS/AF-6) domain family member 6 |
| chr2_-_20425158 | 4.63 |
ENST00000381150.1
|
SDC1
|
syndecan 1 |
| chr2_-_56150910 | 4.59 |
ENST00000424836.2
ENST00000438672.1 ENST00000440439.1 ENST00000429909.1 ENST00000424207.1 ENST00000452337.1 ENST00000355426.3 ENST00000439193.1 ENST00000421664.1 |
EFEMP1
|
EGF containing fibulin-like extracellular matrix protein 1 |
| chr5_+_68711209 | 4.59 |
ENST00000512803.1
|
MARVELD2
|
MARVEL domain containing 2 |
| chr15_+_41136369 | 4.58 |
ENST00000563656.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
| chr17_+_73521763 | 4.58 |
ENST00000167462.5
ENST00000375227.4 ENST00000392550.3 ENST00000578363.1 ENST00000579392.1 |
LLGL2
|
lethal giant larvae homolog 2 (Drosophila) |
| chr16_-_2908155 | 4.56 |
ENST00000571228.1
ENST00000161006.3 |
PRSS22
|
protease, serine, 22 |
| chr2_-_220034712 | 4.56 |
ENST00000409370.2
ENST00000430764.1 ENST00000409878.3 |
SLC23A3
|
solute carrier family 23, member 3 |
| chr7_+_73242490 | 4.49 |
ENST00000431918.1
|
CLDN4
|
claudin 4 |
| chr3_-_48471454 | 4.48 |
ENST00000296440.6
ENST00000448774.2 |
PLXNB1
|
plexin B1 |
| chr6_+_27215494 | 4.47 |
ENST00000230582.3
|
PRSS16
|
protease, serine, 16 (thymus) |
| chr19_-_36499521 | 4.46 |
ENST00000397428.3
ENST00000503121.1 ENST00000340477.5 ENST00000324444.3 ENST00000490730.1 |
SYNE4
|
spectrin repeat containing, nuclear envelope family member 4 |
| chr11_+_71903169 | 4.43 |
ENST00000393676.3
|
FOLR1
|
folate receptor 1 (adult) |
| chr7_+_73242069 | 4.41 |
ENST00000435050.1
|
CLDN4
|
claudin 4 |
| chr16_-_3086927 | 4.37 |
ENST00000572449.1
|
CCDC64B
|
coiled-coil domain containing 64B |
| chr5_+_167718604 | 4.35 |
ENST00000265293.4
|
WWC1
|
WW and C2 domain containing 1 |
| chr14_-_67878917 | 4.32 |
ENST00000216446.4
|
PLEK2
|
pleckstrin 2 |
| chr1_+_201979645 | 4.32 |
ENST00000367284.5
ENST00000367283.3 |
ELF3
|
E74-like factor 3 (ets domain transcription factor, epithelial-specific ) |
| chr9_-_116861337 | 4.31 |
ENST00000374118.3
|
KIF12
|
kinesin family member 12 |
| chr11_+_65554493 | 4.29 |
ENST00000335987.3
|
OVOL1
|
ovo-like zinc finger 1 |
| chr2_+_27665232 | 4.27 |
ENST00000543753.1
ENST00000288873.3 |
KRTCAP3
|
keratinocyte associated protein 3 |
| chr11_+_45944190 | 4.22 |
ENST00000401752.1
ENST00000389968.3 ENST00000325468.5 ENST00000536139.1 |
GYLTL1B
|
glycosyltransferase-like 1B |
| chr17_+_9548845 | 4.19 |
ENST00000570475.1
ENST00000285199.7 |
USP43
|
ubiquitin specific peptidase 43 |
| chr5_+_76114758 | 4.19 |
ENST00000514165.1
ENST00000296677.4 |
F2RL1
|
coagulation factor II (thrombin) receptor-like 1 |
| chr19_+_35739897 | 4.14 |
ENST00000605618.1
ENST00000427250.1 ENST00000601623.1 |
LSR
|
lipolysis stimulated lipoprotein receptor |
| chr22_+_45148432 | 4.12 |
ENST00000389774.2
ENST00000396119.2 ENST00000336963.4 ENST00000356099.6 ENST00000412433.1 |
ARHGAP8
|
Rho GTPase activating protein 8 |
| chr12_+_6419877 | 4.09 |
ENST00000536531.1
|
PLEKHG6
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 6 |
| chr3_+_105086056 | 4.06 |
ENST00000472644.2
|
ALCAM
|
activated leukocyte cell adhesion molecule |
| chr5_-_138725594 | 4.05 |
ENST00000302125.8
|
MZB1
|
marginal zone B and B1 cell-specific protein |
| chr19_+_35739280 | 4.04 |
ENST00000602122.1
|
LSR
|
lipolysis stimulated lipoprotein receptor |
| chr16_+_68678739 | 4.02 |
ENST00000264012.4
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental) |
| chr6_-_31846744 | 4.01 |
ENST00000414427.1
ENST00000229729.6 ENST00000375562.4 |
SLC44A4
|
solute carrier family 44, member 4 |
| chr8_+_95653840 | 3.99 |
ENST00000520385.1
|
ESRP1
|
epithelial splicing regulatory protein 1 |
| chr15_+_41136263 | 3.98 |
ENST00000568823.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
| chrX_+_105969893 | 3.96 |
ENST00000255499.2
|
RNF128
|
ring finger protein 128, E3 ubiquitin protein ligase |
| chr11_+_706219 | 3.96 |
ENST00000533500.1
|
EPS8L2
|
EPS8-like 2 |
| chr1_+_183155373 | 3.95 |
ENST00000493293.1
ENST00000264144.4 |
LAMC2
|
laminin, gamma 2 |
| chr5_+_68711023 | 3.91 |
ENST00000515844.1
|
MARVELD2
|
MARVEL domain containing 2 |
| chr11_+_560956 | 3.91 |
ENST00000397582.3
ENST00000344375.4 ENST00000397583.3 |
RASSF7
|
Ras association (RalGDS/AF-6) domain family (N-terminal) member 7 |
| chr7_+_117120017 | 3.90 |
ENST00000003084.6
ENST00000454343.1 |
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) |
| chrX_+_70443050 | 3.89 |
ENST00000361726.6
|
GJB1
|
gap junction protein, beta 1, 32kDa |
| chr5_+_89854595 | 3.89 |
ENST00000405460.2
|
GPR98
|
G protein-coupled receptor 98 |
| chr12_-_53343602 | 3.87 |
ENST00000546897.1
ENST00000552551.1 |
KRT8
|
keratin 8 |
| chr6_-_47010061 | 3.87 |
ENST00000371253.2
|
GPR110
|
G protein-coupled receptor 110 |
| chr3_-_49459878 | 3.87 |
ENST00000546031.1
ENST00000458307.2 ENST00000430521.1 |
AMT
|
aminomethyltransferase |
| chr19_-_36001113 | 3.86 |
ENST00000434389.1
|
DMKN
|
dermokine |
| chr19_+_11350278 | 3.86 |
ENST00000252453.8
|
C19orf80
|
chromosome 19 open reading frame 80 |
| chr20_+_49348109 | 3.86 |
ENST00000396039.1
|
PARD6B
|
par-6 family cell polarity regulator beta |
| chr20_+_49348081 | 3.86 |
ENST00000371610.2
|
PARD6B
|
par-6 family cell polarity regulator beta |
| chr18_-_47721447 | 3.84 |
ENST00000285039.7
|
MYO5B
|
myosin VB |
| chr1_-_43751230 | 3.83 |
ENST00000523677.1
|
C1orf210
|
chromosome 1 open reading frame 210 |
| chr2_+_27665289 | 3.81 |
ENST00000407293.1
|
KRTCAP3
|
keratinocyte associated protein 3 |
| chr1_-_40367668 | 3.76 |
ENST00000397332.2
ENST00000429311.1 |
MYCL
|
v-myc avian myelocytomatosis viral oncogene lung carcinoma derived homolog |
| chr10_+_43867077 | 3.76 |
ENST00000476166.1
|
FXYD4
|
FXYD domain containing ion transport regulator 4 |
| chr5_-_54281491 | 3.75 |
ENST00000381405.4
|
ESM1
|
endothelial cell-specific molecule 1 |
| chr5_-_138725560 | 3.73 |
ENST00000412103.2
ENST00000457570.2 |
MZB1
|
marginal zone B and B1 cell-specific protein |
| chr6_-_132722604 | 3.70 |
ENST00000392401.3
ENST00000367963.3 |
MOXD1
|
monooxygenase, DBH-like 1 |
| chr11_-_560703 | 3.68 |
ENST00000441853.1
ENST00000329451.3 |
C11orf35
|
chromosome 11 open reading frame 35 |
| chr1_-_47655686 | 3.67 |
ENST00000294338.2
|
PDZK1IP1
|
PDZK1 interacting protein 1 |
| chr16_+_68678892 | 3.64 |
ENST00000429102.2
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental) |
| chr2_-_89417335 | 3.63 |
ENST00000490686.1
|
IGKV1-17
|
immunoglobulin kappa variable 1-17 |
| chr19_+_3721719 | 3.59 |
ENST00000589378.1
ENST00000382008.3 |
TJP3
|
tight junction protein 3 |
| chr16_-_20367584 | 3.58 |
ENST00000570689.1
|
UMOD
|
uromodulin |
| chr2_-_241835561 | 3.57 |
ENST00000388934.4
|
C2orf54
|
chromosome 2 open reading frame 54 |
| chr2_+_234602305 | 3.55 |
ENST00000406651.1
|
UGT1A6
|
UDP glucuronosyltransferase 1 family, polypeptide A6 |
| chr1_-_207206092 | 3.54 |
ENST00000359470.5
ENST00000461135.2 |
C1orf116
|
chromosome 1 open reading frame 116 |
| chr1_+_27189631 | 3.53 |
ENST00000339276.4
|
SFN
|
stratifin |
| chr12_-_103310987 | 3.50 |
ENST00000307000.2
|
PAH
|
phenylalanine hydroxylase |
| chr4_+_106816644 | 3.49 |
ENST00000506666.1
ENST00000503451.1 |
NPNT
|
nephronectin |
| chr16_-_86542652 | 3.49 |
ENST00000599749.1
|
FENDRR
|
FOXF1 adjacent non-coding developmental regulatory RNA |
| chrX_-_3264682 | 3.47 |
ENST00000217939.6
|
MXRA5
|
matrix-remodelling associated 5 |
| chr19_-_7990991 | 3.45 |
ENST00000318978.4
|
CTXN1
|
cortexin 1 |
| chr1_-_85514120 | 3.44 |
ENST00000370589.2
ENST00000341115.4 ENST00000370587.1 |
MCOLN3
|
mucolipin 3 |
| chr8_-_79717750 | 3.42 |
ENST00000263851.4
ENST00000379113.2 |
IL7
|
interleukin 7 |
| chr1_+_16375284 | 3.42 |
ENST00000375667.3
|
CLCNKB
|
chloride channel, voltage-sensitive Kb |
| chr11_+_706595 | 3.42 |
ENST00000531348.1
ENST00000530636.1 |
EPS8L2
|
EPS8-like 2 |
| chr16_+_84402098 | 3.41 |
ENST00000262429.4
ENST00000416219.2 |
ATP2C2
|
ATPase, Ca++ transporting, type 2C, member 2 |
| chr4_-_74486109 | 3.37 |
ENST00000395777.2
|
RASSF6
|
Ras association (RalGDS/AF-6) domain family member 6 |
| chr7_-_98030360 | 3.37 |
ENST00000005260.8
|
BAIAP2L1
|
BAI1-associated protein 2-like 1 |
| chr2_+_47596634 | 3.37 |
ENST00000419334.1
|
EPCAM
|
epithelial cell adhesion molecule |
| chr6_-_41715128 | 3.36 |
ENST00000356667.4
ENST00000373025.3 ENST00000425343.2 |
PGC
|
progastricsin (pepsinogen C) |
| chr16_+_68679193 | 3.35 |
ENST00000581171.1
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental) |
| chr22_+_23229960 | 3.34 |
ENST00000526893.1
ENST00000532223.2 ENST00000531372.1 |
IGLL5
|
immunoglobulin lambda-like polypeptide 5 |
| chr19_+_35606692 | 3.34 |
ENST00000406242.3
ENST00000454903.2 |
FXYD3
|
FXYD domain containing ion transport regulator 3 |
| chrX_+_48620147 | 3.34 |
ENST00000303227.6
|
GLOD5
|
glyoxalase domain containing 5 |
| chr16_-_20364030 | 3.34 |
ENST00000396134.2
ENST00000573567.1 ENST00000570757.1 ENST00000424589.1 ENST00000302509.4 ENST00000571174.1 ENST00000576688.1 |
UMOD
|
uromodulin |
| chr1_-_55266926 | 3.33 |
ENST00000371276.4
|
TTC22
|
tetratricopeptide repeat domain 22 |
| chr19_+_55591743 | 3.32 |
ENST00000588359.1
ENST00000245618.5 |
EPS8L1
|
EPS8-like 1 |
| chr4_+_85504075 | 3.32 |
ENST00000295887.5
|
CDS1
|
CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1 |
| chr17_-_31204124 | 3.31 |
ENST00000579584.1
ENST00000318217.5 ENST00000583621.1 |
MYO1D
|
myosin ID |
| chr3_-_45187843 | 3.29 |
ENST00000296129.1
ENST00000425231.2 |
CDCP1
|
CUB domain containing protein 1 |
Network of associatons between targets according to the STRING database.
First level regulatory network of ZEB1
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 6.6 | 45.9 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 4.3 | 8.6 | GO:0001983 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
| 4.0 | 23.9 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 3.5 | 10.4 | GO:0048627 | myoblast development(GO:0048627) |
| 3.1 | 12.4 | GO:0097195 | pilomotor reflex(GO:0097195) |
| 3.1 | 9.2 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
| 3.1 | 3.1 | GO:0032402 | melanosome transport(GO:0032402) |
| 2.8 | 11.0 | GO:1902910 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
| 2.7 | 2.7 | GO:0044062 | regulation of excretion(GO:0044062) |
| 2.6 | 2.6 | GO:0060738 | epithelial-mesenchymal signaling involved in prostate gland development(GO:0060738) |
| 2.5 | 7.4 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
| 2.2 | 6.7 | GO:0061713 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
| 2.1 | 14.7 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
| 2.0 | 9.8 | GO:0072233 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
| 1.8 | 5.4 | GO:0043311 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
| 1.8 | 12.5 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
| 1.7 | 13.9 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 1.7 | 11.6 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 1.6 | 6.6 | GO:1902161 | positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
| 1.6 | 23.4 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 1.6 | 29.7 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 1.5 | 7.6 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
| 1.5 | 19.5 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
| 1.5 | 54.9 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 1.4 | 7.1 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 1.4 | 4.2 | GO:0048925 | lateral line system development(GO:0048925) |
| 1.4 | 19.0 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
| 1.4 | 5.4 | GO:0070662 | mast cell proliferation(GO:0070662) |
| 1.3 | 4.0 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 1.3 | 5.2 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 1.3 | 1.3 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
| 1.3 | 7.6 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
| 1.3 | 16.4 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
| 1.3 | 8.8 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 1.2 | 8.4 | GO:1902896 | terminal web assembly(GO:1902896) |
| 1.2 | 1.2 | GO:1903970 | negative regulation of macrophage colony-stimulating factor signaling pathway(GO:1902227) negative regulation of response to macrophage colony-stimulating factor(GO:1903970) negative regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903973) |
| 1.2 | 8.2 | GO:0045229 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 1.2 | 7.0 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 1.1 | 4.6 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
| 1.1 | 1.1 | GO:0060667 | fibroblast growth factor receptor signaling pathway involved in mammary gland specification(GO:0060595) mammary gland bud formation(GO:0060615) branch elongation involved in salivary gland morphogenesis(GO:0060667) mesenchymal cell differentiation involved in lung development(GO:0060915) |
| 1.1 | 4.6 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
| 1.1 | 3.4 | GO:0042710 | iron assimilation(GO:0033212) iron assimilation by chelation and transport(GO:0033214) biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) positive regulation of bone mineralization involved in bone maturation(GO:1900159) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) negative regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000308) |
| 1.1 | 1.1 | GO:0060482 | lobar bronchus development(GO:0060482) |
| 1.1 | 3.2 | GO:0021650 | vestibulocochlear nerve formation(GO:0021650) |
| 1.1 | 3.2 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) negative regulation of chloride transport(GO:2001226) |
| 1.0 | 3.1 | GO:1900085 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
| 1.0 | 5.1 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
| 1.0 | 1.0 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
| 1.0 | 2.0 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
| 1.0 | 17.0 | GO:0002934 | desmosome organization(GO:0002934) |
| 1.0 | 4.9 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 1.0 | 3.9 | GO:0048496 | maintenance of organ identity(GO:0048496) |
| 1.0 | 1.0 | GO:0002663 | B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
| 1.0 | 2.9 | GO:2000910 | negative regulation of cholesterol import(GO:0060621) negative regulation of sterol import(GO:2000910) |
| 1.0 | 10.5 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.9 | 2.8 | GO:0043318 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) regulation of cytotoxic T cell degranulation(GO:0043317) negative regulation of cytotoxic T cell degranulation(GO:0043318) |
| 0.9 | 3.8 | GO:0044028 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.9 | 13.2 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.9 | 4.7 | GO:0048749 | compound eye development(GO:0048749) |
| 0.9 | 12.2 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.9 | 9.2 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.9 | 1.8 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.9 | 14.4 | GO:0055062 | phosphate ion homeostasis(GO:0055062) trivalent inorganic anion homeostasis(GO:0072506) |
| 0.9 | 7.2 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
| 0.9 | 5.3 | GO:0072221 | distal convoluted tubule development(GO:0072025) metanephric distal convoluted tubule development(GO:0072221) |
| 0.9 | 5.2 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 0.9 | 2.6 | GO:0002585 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 0.9 | 7.7 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 0.9 | 5.1 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.9 | 3.4 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
| 0.9 | 1.7 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
| 0.8 | 2.5 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
| 0.8 | 3.3 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.8 | 3.3 | GO:0044691 | tooth eruption(GO:0044691) |
| 0.8 | 4.2 | GO:1901994 | negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 0.8 | 5.8 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.8 | 3.3 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.8 | 1.6 | GO:0072039 | regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072039) negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072040) mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:1901145) negative regulation of somatic stem cell population maintenance(GO:1904673) |
| 0.8 | 6.4 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.8 | 2.4 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.8 | 10.2 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.8 | 2.4 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
| 0.8 | 14.1 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.8 | 3.9 | GO:0035962 | response to interleukin-13(GO:0035962) |
| 0.8 | 2.3 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
| 0.8 | 12.8 | GO:0070673 | response to interleukin-18(GO:0070673) |
| 0.7 | 4.4 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.7 | 3.7 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
| 0.7 | 14.7 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.7 | 7.3 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.7 | 5.0 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
| 0.7 | 3.6 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.7 | 7.1 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 0.7 | 0.7 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
| 0.7 | 1.4 | GO:0046677 | response to antibiotic(GO:0046677) |
| 0.7 | 2.8 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.7 | 4.2 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.7 | 1.4 | GO:2001201 | regulation of transforming growth factor-beta secretion(GO:2001201) |
| 0.7 | 4.0 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.7 | 2.0 | GO:0070904 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.7 | 3.3 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.7 | 6.7 | GO:0061218 | negative regulation of mesonephros development(GO:0061218) negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
| 0.7 | 7.3 | GO:0032494 | response to peptidoglycan(GO:0032494) |
| 0.7 | 0.7 | GO:1902232 | regulation of positive thymic T cell selection(GO:1902232) |
| 0.7 | 2.0 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
| 0.7 | 10.5 | GO:0015871 | choline transport(GO:0015871) |
| 0.6 | 1.9 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
| 0.6 | 0.6 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 0.6 | 3.2 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
| 0.6 | 3.2 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
| 0.6 | 3.1 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
| 0.6 | 1.9 | GO:0043105 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
| 0.6 | 3.1 | GO:0003409 | optic cup structural organization(GO:0003409) |
| 0.6 | 3.7 | GO:0042816 | vitamin B6 metabolic process(GO:0042816) |
| 0.6 | 1.8 | GO:1902908 | regulation of melanosome transport(GO:1902908) |
| 0.6 | 1.2 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.6 | 2.9 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
| 0.6 | 2.9 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
| 0.6 | 17.2 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
| 0.6 | 8.0 | GO:1901166 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
| 0.6 | 0.6 | GO:0097069 | response to human chorionic gonadotropin(GO:0044752) cellular response to thyroxine stimulus(GO:0097069) cellular response to L-phenylalanine derivative(GO:1904387) |
| 0.6 | 0.6 | GO:0021840 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
| 0.6 | 4.4 | GO:0021592 | fourth ventricle development(GO:0021592) |
| 0.6 | 54.3 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
| 0.5 | 3.3 | GO:0060214 | endocardium formation(GO:0060214) |
| 0.5 | 3.8 | GO:2000035 | regulation of stem cell division(GO:2000035) |
| 0.5 | 2.7 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
| 0.5 | 2.1 | GO:0003335 | corneocyte development(GO:0003335) |
| 0.5 | 1.5 | GO:1903489 | epithelial cell differentiation involved in salivary gland development(GO:0060690) epithelial cell maturation involved in salivary gland development(GO:0060691) regulation of plasma cell differentiation(GO:1900098) positive regulation of plasma cell differentiation(GO:1900100) positive regulation of lactation(GO:1903489) |
| 0.5 | 4.1 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
| 0.5 | 8.2 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.5 | 1.5 | GO:1901253 | negative regulation of intracellular transport of viral material(GO:1901253) |
| 0.5 | 2.0 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.5 | 1.5 | GO:0031247 | actin rod assembly(GO:0031247) |
| 0.5 | 2.0 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
| 0.5 | 3.9 | GO:0032439 | endosome localization(GO:0032439) |
| 0.5 | 1.4 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
| 0.5 | 1.4 | GO:1904899 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 0.5 | 1.4 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.5 | 2.8 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 0.5 | 1.9 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
| 0.5 | 1.8 | GO:0045401 | response to molecule of fungal origin(GO:0002238) regulation of interleukin-3 production(GO:0032672) positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) cellular response to molecule of fungal origin(GO:0071226) |
| 0.5 | 1.8 | GO:0051563 | smooth endoplasmic reticulum calcium ion homeostasis(GO:0051563) |
| 0.4 | 1.3 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.4 | 0.9 | GO:0051665 | membrane raft localization(GO:0051665) |
| 0.4 | 2.1 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 0.4 | 1.3 | GO:0051549 | positive regulation of keratinocyte migration(GO:0051549) |
| 0.4 | 5.0 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.4 | 8.4 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
| 0.4 | 5.8 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
| 0.4 | 6.5 | GO:0031268 | pseudopodium organization(GO:0031268) |
| 0.4 | 1.2 | GO:1903625 | negative regulation of DNA catabolic process(GO:1903625) |
| 0.4 | 4.5 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.4 | 66.0 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 0.4 | 2.8 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
| 0.4 | 2.4 | GO:0071504 | cellular response to heparin(GO:0071504) |
| 0.4 | 1.6 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 0.4 | 0.8 | GO:0002040 | sprouting angiogenesis(GO:0002040) |
| 0.4 | 1.2 | GO:0042938 | dipeptide transport(GO:0042938) |
| 0.4 | 14.4 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.4 | 1.9 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 0.4 | 3.9 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.4 | 0.4 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 0.4 | 4.6 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.4 | 6.9 | GO:0016264 | gap junction assembly(GO:0016264) |
| 0.4 | 8.3 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.4 | 1.9 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
| 0.4 | 1.5 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
| 0.4 | 3.7 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
| 0.4 | 5.1 | GO:0015705 | iodide transport(GO:0015705) |
| 0.4 | 2.6 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.4 | 1.1 | GO:1901291 | negative regulation of double-strand break repair via single-strand annealing(GO:1901291) |
| 0.4 | 2.2 | GO:0099540 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
| 0.4 | 1.1 | GO:0060752 | negative regulation of intestinal phytosterol absorption(GO:0010949) negative regulation of intestinal cholesterol absorption(GO:0045796) intestinal phytosterol absorption(GO:0060752) negative regulation of intestinal lipid absorption(GO:1904730) |
| 0.4 | 11.5 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
| 0.4 | 1.8 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.4 | 0.7 | GO:0060086 | circadian temperature homeostasis(GO:0060086) |
| 0.4 | 1.4 | GO:2000510 | regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 0.3 | 1.0 | GO:0086098 | angiotensin-activated signaling pathway involved in heart process(GO:0086098) |
| 0.3 | 3.5 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.3 | 1.0 | GO:2000449 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) positive regulation of necroptotic process(GO:0060545) regulation of T cell extravasation(GO:2000407) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
| 0.3 | 3.8 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) |
| 0.3 | 1.7 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.3 | 11.9 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
| 0.3 | 8.9 | GO:0034063 | stress granule assembly(GO:0034063) |
| 0.3 | 1.3 | GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
| 0.3 | 0.3 | GO:1903719 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.3 | 1.0 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
| 0.3 | 1.7 | GO:0018262 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 0.3 | 0.7 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
| 0.3 | 6.6 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.3 | 1.6 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
| 0.3 | 6.4 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.3 | 4.4 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.3 | 2.9 | GO:1902903 | regulation of fibril organization(GO:1902903) |
| 0.3 | 9.5 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.3 | 4.4 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
| 0.3 | 1.6 | GO:0033123 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 0.3 | 2.2 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.3 | 1.5 | GO:0030070 | insulin processing(GO:0030070) |
| 0.3 | 1.2 | GO:0090194 | negative regulation of glomerular mesangial cell proliferation(GO:0072125) posterior mesonephric tubule development(GO:0072166) negative regulation of metanephric glomerulus development(GO:0072299) regulation of metanephric glomerular mesangial cell proliferation(GO:0072301) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) negative regulation of glomerulus development(GO:0090194) |
| 0.3 | 3.0 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
| 0.3 | 0.9 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
| 0.3 | 12.6 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
| 0.3 | 0.3 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
| 0.3 | 1.2 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
| 0.3 | 0.6 | GO:0002840 | B cell cytokine production(GO:0002368) T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
| 0.3 | 0.6 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
| 0.3 | 1.2 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) deoxyribonucleoside diphosphate metabolic process(GO:0009186) dADP metabolic process(GO:0046056) dGDP metabolic process(GO:0046066) |
| 0.3 | 2.1 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
| 0.3 | 2.9 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) |
| 0.3 | 1.2 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
| 0.3 | 0.9 | GO:0044278 | cell wall disruption in other organism(GO:0044278) |
| 0.3 | 3.2 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 0.3 | 2.3 | GO:0006477 | protein sulfation(GO:0006477) |
| 0.3 | 1.4 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
| 0.3 | 1.1 | GO:1903382 | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
| 0.3 | 4.0 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.3 | 0.9 | GO:1904617 | negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
| 0.3 | 0.9 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
| 0.3 | 1.4 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
| 0.3 | 4.2 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
| 0.3 | 1.4 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
| 0.3 | 1.1 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 0.3 | 2.2 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 0.3 | 0.5 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
| 0.3 | 3.6 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 0.3 | 1.9 | GO:0051962 | positive regulation of nervous system development(GO:0051962) |
| 0.3 | 2.2 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
| 0.3 | 1.6 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
| 0.3 | 1.3 | GO:0043335 | protein unfolding(GO:0043335) |
| 0.3 | 0.3 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 0.3 | 1.3 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.3 | 19.8 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
| 0.3 | 5.5 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.3 | 2.9 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.3 | 0.3 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
| 0.3 | 18.5 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 0.3 | 6.5 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.3 | 3.1 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
| 0.3 | 1.3 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.3 | 0.8 | GO:0035038 | female pronucleus assembly(GO:0035038) |
| 0.3 | 1.0 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
| 0.3 | 1.3 | GO:0070295 | renal water absorption(GO:0070295) |
| 0.3 | 4.5 | GO:0009713 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
| 0.3 | 1.3 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.3 | 1.0 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
| 0.2 | 1.7 | GO:0044245 | polysaccharide digestion(GO:0044245) |
| 0.2 | 4.4 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
| 0.2 | 1.2 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
| 0.2 | 1.7 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
| 0.2 | 3.4 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
| 0.2 | 6.3 | GO:0033622 | integrin activation(GO:0033622) |
| 0.2 | 0.7 | GO:0032908 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) |
| 0.2 | 1.0 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
| 0.2 | 1.7 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
| 0.2 | 41.9 | GO:0008543 | fibroblast growth factor receptor signaling pathway(GO:0008543) |
| 0.2 | 1.4 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
| 0.2 | 0.9 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
| 0.2 | 0.7 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 0.2 | 0.5 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
| 0.2 | 0.9 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.2 | 0.9 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
| 0.2 | 1.6 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 0.2 | 2.8 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.2 | 0.7 | GO:0071586 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
| 0.2 | 1.4 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.2 | 0.5 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
| 0.2 | 3.2 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.2 | 1.4 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
| 0.2 | 2.7 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.2 | 2.7 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
| 0.2 | 2.4 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 0.2 | 1.3 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 0.2 | 6.7 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
| 0.2 | 3.5 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.2 | 3.0 | GO:0030183 | B cell differentiation(GO:0030183) |
| 0.2 | 2.6 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.2 | 6.8 | GO:0036065 | fucosylation(GO:0036065) |
| 0.2 | 0.6 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
| 0.2 | 3.8 | GO:0097205 | renal filtration(GO:0097205) |
| 0.2 | 1.7 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 0.2 | 1.1 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.2 | 0.4 | GO:0006517 | protein deglycosylation(GO:0006517) |
| 0.2 | 1.0 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.2 | 0.8 | GO:0070997 | neuron death(GO:0070997) |
| 0.2 | 4.9 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.2 | 1.4 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
| 0.2 | 0.2 | GO:1904815 | negative regulation of protein localization to chromosome, telomeric region(GO:1904815) |
| 0.2 | 0.6 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
| 0.2 | 1.2 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
| 0.2 | 0.6 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.2 | 3.7 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
| 0.2 | 3.5 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 0.2 | 0.6 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
| 0.2 | 1.5 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.2 | 0.9 | GO:1904245 | regulation of polynucleotide adenylyltransferase activity(GO:1904245) |
| 0.2 | 3.6 | GO:0015732 | prostaglandin transport(GO:0015732) |
| 0.2 | 6.7 | GO:0015893 | drug transport(GO:0015893) |
| 0.2 | 2.1 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
| 0.2 | 1.7 | GO:0015884 | folic acid transport(GO:0015884) |
| 0.2 | 0.9 | GO:0030573 | bile acid catabolic process(GO:0030573) |
| 0.2 | 0.6 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
| 0.2 | 0.9 | GO:0033383 | geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) farnesyl diphosphate biosynthetic process(GO:0045337) |
| 0.2 | 3.3 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
| 0.2 | 0.7 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.2 | 0.5 | GO:0007518 | myoblast fate determination(GO:0007518) |
| 0.2 | 4.1 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.2 | 10.4 | GO:0018149 | peptide cross-linking(GO:0018149) |
| 0.2 | 0.4 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.2 | 2.3 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
| 0.2 | 0.2 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.2 | 0.7 | GO:0034343 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
| 0.2 | 2.2 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
| 0.2 | 3.4 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
| 0.2 | 0.5 | GO:0051389 | inactivation of MAPKK activity(GO:0051389) |
| 0.2 | 3.8 | GO:0003416 | endochondral bone growth(GO:0003416) |
| 0.2 | 3.6 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.2 | 0.9 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
| 0.2 | 0.5 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
| 0.2 | 0.5 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
| 0.2 | 1.0 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 0.2 | 1.3 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.2 | 0.8 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
| 0.2 | 0.7 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.2 | 0.5 | GO:1990637 | response to prolactin(GO:1990637) |
| 0.2 | 3.0 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.2 | 1.5 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.2 | 2.6 | GO:0046415 | urate metabolic process(GO:0046415) |
| 0.2 | 0.7 | GO:0052651 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.2 | 0.8 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.2 | 0.8 | GO:0002353 | kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) |
| 0.2 | 1.1 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.2 | 10.6 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
| 0.2 | 1.1 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 0.2 | 1.1 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
| 0.2 | 1.6 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 0.2 | 0.5 | GO:1902668 | negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
| 0.2 | 0.5 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 0.2 | 2.0 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.2 | 0.5 | GO:0046081 | dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
| 0.2 | 1.9 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.2 | 0.8 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.2 | 1.6 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.2 | 0.2 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
| 0.2 | 1.7 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 0.2 | 2.9 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
| 0.2 | 1.2 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
| 0.2 | 0.5 | GO:0044209 | AMP salvage(GO:0044209) |
| 0.1 | 2.7 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.1 | 1.2 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
| 0.1 | 0.9 | GO:0051546 | keratinocyte migration(GO:0051546) |
| 0.1 | 0.4 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal lipid absorption(GO:1904729) |
| 0.1 | 2.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 0.1 | 1.6 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.1 | 1.4 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.1 | 0.4 | GO:1990869 | response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
| 0.1 | 2.3 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
| 0.1 | 0.9 | GO:0051715 | cytolysis in other organism(GO:0051715) |
| 0.1 | 0.4 | GO:0038188 | cholecystokinin signaling pathway(GO:0038188) |
| 0.1 | 0.8 | GO:1902460 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.1 | 1.7 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
| 0.1 | 2.1 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
| 0.1 | 0.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
| 0.1 | 0.3 | GO:0042335 | cuticle development(GO:0042335) |
| 0.1 | 0.6 | GO:0035754 | B cell chemotaxis(GO:0035754) |
| 0.1 | 1.2 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 0.1 | 1.1 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
| 0.1 | 1.8 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.1 | 2.0 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
| 0.1 | 2.4 | GO:0015816 | glycine transport(GO:0015816) |
| 0.1 | 0.8 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 0.1 | 0.4 | GO:0019085 | early viral transcription(GO:0019085) |
| 0.1 | 3.2 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.1 | 3.0 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
| 0.1 | 0.5 | GO:0015853 | adenine transport(GO:0015853) |
| 0.1 | 1.0 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
| 0.1 | 7.6 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.1 | 0.8 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
| 0.1 | 0.5 | GO:0050925 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) negative regulation of negative chemotaxis(GO:0050925) |
| 0.1 | 0.8 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.1 | 4.6 | GO:0098927 | vesicle-mediated transport between endosomal compartments(GO:0098927) |
| 0.1 | 0.8 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
| 0.1 | 2.4 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 0.1 | 1.3 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.1 | 0.4 | GO:0048162 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
| 0.1 | 2.7 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
| 0.1 | 0.5 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.1 | 1.1 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
| 0.1 | 17.9 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
| 0.1 | 1.2 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
| 0.1 | 0.4 | GO:0043438 | acetoacetic acid metabolic process(GO:0043438) |
| 0.1 | 0.8 | GO:0072319 | vesicle uncoating(GO:0072319) |
| 0.1 | 1.2 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.1 | 0.6 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.1 | 0.8 | GO:0046104 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.1 | 0.7 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.1 | 1.2 | GO:0046465 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
| 0.1 | 3.3 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.1 | 0.1 | GO:0010447 | response to acidic pH(GO:0010447) |
| 0.1 | 1.0 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
| 0.1 | 0.2 | GO:0003149 | membranous septum morphogenesis(GO:0003149) |
| 0.1 | 0.5 | GO:1904044 | response to aldosterone(GO:1904044) |
| 0.1 | 4.0 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
| 0.1 | 1.6 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
| 0.1 | 0.7 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 0.1 | 0.5 | GO:0070092 | glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
| 0.1 | 1.3 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.1 | 0.3 | GO:1902559 | 3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
| 0.1 | 1.0 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.1 | 0.3 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
| 0.1 | 1.9 | GO:1903874 | ferrous iron transport(GO:0015684) ferrous iron transmembrane transport(GO:1903874) |
| 0.1 | 0.3 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.1 | 0.5 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.1 | 0.7 | GO:0001661 | conditioned taste aversion(GO:0001661) |
| 0.1 | 0.2 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) positive regulation of NAD(P)H oxidase activity(GO:0033864) |
| 0.1 | 0.5 | GO:0036089 | cleavage furrow formation(GO:0036089) |
| 0.1 | 0.4 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |